Search alternatives:
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
main decrease » gain decreased (Expand Search), point decrease (Expand Search), small decrease (Expand Search)
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
main decrease » gain decreased (Expand Search), point decrease (Expand Search), small decrease (Expand Search)
-
1
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
2
-
3
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
4
-
5
-
6
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
7
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”
-
8
-
9
-
10
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
11
-
12
-
13
Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis.
Published 2025Subjects: -
14
-
15
-
16
-
17
-
18
-
19
-
20